Assertio ASRT Stock
Assertio Price Chart
Assertio ASRT Financial and Trading Overview
Assertio stock price | 0.67 USD |
Previous Close | 6.03 USD |
Open | 6.02 USD |
Bid | 0 USD x 1200 |
Ask | 0 USD x 1000 |
Day's Range | 5.92 - 6.18 USD |
52 Week Range | 2.07 - 8.01 USD |
Volume | 990.55K USD |
Avg. Volume | 1.93M USD |
Market Cap | 346.82M USD |
Beta (5Y Monthly) | 1.393309 |
PE Ratio (TTM) | 3.5085714 |
EPS (TTM) | -0.23 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.75 USD |
ASRT Valuation Measures
Enterprise Value | 305.98M USD |
Trailing P/E | 3.5085714 |
Forward P/E | 10.065574 |
PEG Ratio (5 yr expected) | 0.65 |
Price/Sales (ttm) | 2.1387465 |
Price/Book (mrq) | 1.3635354 |
Enterprise Value/Revenue | 1.887 |
Enterprise Value/EBITDA | 3.456 |
Trading Information
Assertio Stock Price History
Beta (5Y Monthly) | 1.393309 |
52-Week Change | 120.86% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8.01 USD |
52 Week Low | 2.07 USD |
50-Day Moving Average | 6.29 USD |
200-Day Moving Average | 4.39 USD |
ASRT Share Statistics
Avg. Volume (3 month) | 1.93M USD |
Avg. Daily Volume (10-Days) | 1.16M USD |
Shares Outstanding | 56.49M |
Float | 54.03M |
Short Ratio | 4.72 |
% Held by Insiders | 1.89% |
% Held by Institutions | 33.97% |
Shares Short | 10.17M |
Short % of Float | 18.35% |
Short % of Shares Outstanding | 18.00% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 59.86% |
Operating Margin (ttm) | 35.36% |
Gross Margin | 88.02% |
EBITDA Margin | 54.59% |
Management Effectiveness
Return on Assets (ttm) | 9.51% |
Return on Equity (ttm) | 53.55% |
Income Statement
Revenue (ttm) | 162.16M USD |
Revenue Per Share (ttm) | 3.35 USD |
Quarterly Revenue Growth (yoy) | 16.19% |
Gross Profit (ttm) | 137.49M USD |
EBITDA | 88.54M USD |
Net Income Avi to Common (ttm) | 97.08M USD |
Diluted EPS (ttm) | 1.75 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 68.6M USD |
Total Cash Per Share (mrq) | 1.23 USD |
Total Debt (mrq) | 38.93M USD |
Total Debt/Equity (mrq) | 15.53 USD |
Current Ratio (mrq) | 1.458 |
Book Value Per Share (mrq) | 4.503 |
Cash Flow Statement
Operating Cash Flow (ttm) | 73.89M USD |
Levered Free Cash Flow (ttm) | 8.78M USD |
Profile of Assertio
Country | United States |
State | IL |
City | Lake Forest |
Address | 100 South Saunders Road |
ZIP | 60045 |
Phone | 224 419 7106 |
Website | https://www.assertiotx.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 30 |
Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.
Q&A For Assertio Stock
What is a current ASRT stock price?
Assertio ASRT stock price today per share is 0.67 USD.
How to purchase Assertio stock?
You can buy ASRT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Assertio?
The stock symbol or ticker of Assertio is ASRT.
Which industry does the Assertio company belong to?
The Assertio industry is Drug Manufacturers-Specialty & Generic.
How many shares does Assertio have in circulation?
The max supply of Assertio shares is 95.77M.
What is Assertio Price to Earnings Ratio (PE Ratio)?
Assertio PE Ratio is now.
What was Assertio earnings per share over the trailing 12 months (TTM)?
Assertio EPS is -0.23 USD over the trailing 12 months.
Which sector does the Assertio company belong to?
The Assertio sector is Healthcare.
Assertio ASRT included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 17601.05 USD — |
+0.87
|
8.38B USD — | 17181.27 USD — | 17716.52 USD — | — - | 8.38B USD — |
NASDAQ HealthCare IXHC | 942.47 USD — |
+1.43
|
— — | 920.56 USD — | 943.62 USD — | — - | — — |
- {{ link.label }} {{link}}